In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 98 for your search:
Drug:  capecitabine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: GENENTECH-AVF2119g, GUMC-00299, MSKCC-01008, UAB-0028, UAB-F001009003, NCT00012285

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 65 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068891, U10CA031946, CALGB-49907, ECOG-CALGB-49907, CAN-NCIC-MAC1, SWOG-CALGB-49907, MAC1, NCT00024102

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NSABP R-04, CALGB-NSABP-R-04, NCT00058474

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CDR0000427299, P30CA016042, UCLA-0412086-01, ROCHE-BO17920A, NCT00112918

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NSABP B-40, NCT00408408

6.

Phase: Phase III
Type: Health services research, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02516, CDR0000667089, GOG-0241, U10CA027469, UCL-07/095, UCL-mEOC, ISRCTN83438782, EUDRACT-2008-000837-23, EU-21007, NCRI-UCL-07/095, CRUK-UCL-07/095, NCT01081262

7.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000681540, WRAMC-8214, USMCI-8214/ACOSOG-Z6091, 8214, NCT01167725

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01442, MC0131, WSU-C-2679, MAYO-MC0131, NCI-5599, CDR0000331694, N01CM62205, 5599, NCT00070252

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00108, CDR0000434851, 0501007709, 6981, N01CM62204, P30CA013330, AECM-0501007709, NYWCCC-0501007709, NCI-6981, NCT00121251

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 06-248, NCT00438256

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 59
Sponsor: NCI, Other
Protocol IDs: LCCC 9904, UNC-9904, NCI-G00-1834, CDR0000068119, NCT00006108

12.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, NIH WGMCC
Protocol IDs: 010172, NCI-01-C-0172, MB-NAVY-00-07, MB-NAVY-B01-008, CDR0000068741, NCT00021047

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: MSKCC-98112, NCI-G99-1556, NCT00004012

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067422, U10CA031946, CLB-39807, CALGB-39807, NCT00004183

15.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-00-C-0149, NCT00020241

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000068633, GOG-0076CC, NCT00016926

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-01866, N9945, CDR0000069011, NCCTG-N9945, NSABP-CI-66, U10CA025224, NCT00026234

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: GOG-0128G, NCI-2012-02469, CDR0000069384, U10CA027469, NCT00039442

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069413, NCCTG-N0149, N0149, NCT00040859

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069488, CLB-90008, CALGB-90008, NCT00042965

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 70 and over OR 18 to 59
Sponsor: NCI, Other
Protocol IDs: CDR0000258049, S0030, U10CA032102, SWOG-S0030, NCT00049335

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000270681, NCCTG-N0242, N0242, NCT00054457

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000288820, U10CA032102, S0312, SWOG-S0312, NCT00058318

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-03-C-0300, NCT00072241

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0247, CDR0000350136, NCT00081289
1     
New Search